Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026)
Bio-Techne (TECH) recorded quarterly Other Accumulated Expenses of $2.1 million in Q1 2026, up 32.57% quarter-over-quarter from $1.6 million in Q4 2025, and up 15.39% on a YoY basis from $1.8 million in Q1 2025.
Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Bio-Techne's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 15.39% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 15.39% YoY), while the FY2025 annual figure was $1.6 million, down 23.52% from the prior year.
- Other Accumulated Expenses was $2.1 million for Q1 2026 at Bio-Techne, up from $1.6 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $4.5 million in Q3 2025 to a low of $865000.0 in Q1 2023.
- Historically, Other Accumulated Expenses has averaged $2.5 million across 5 years, with a median of $2.1 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses slumped 75.87% in 2022, then jumped 240.92% in 2024.
- A 5-year view of Other Accumulated Expenses shows it stood at $1.3 million in 2022, then soared by 220.32% to $4.2 million in 2023, then slumped by 37.7% to $2.6 million in 2024, then plunged by 40.05% to $1.6 million in 2025, then surged by 32.57% to $2.1 million in 2026.
- The last three Other Accumulated Expenses figures came in at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.09 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 4.23 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 865,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 5.47 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 3.89 Mn |